Patents by Inventor Robert Jiang

Robert Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Network Architecture, Methods, and Devices for a Wireless Communications Network
    Publication number: 20240421931
    Abstract: Methods and apparatus in a fifth-generation wireless communications, including an example method, in a wireless device, that includes receiving a downlink signal comprising an uplink access configuration index, using the uplink access configuration index to identify an uplink access configuration from among a predetermined plurality of uplink access configurations, and transmitting to the wireless communications network according to the identified uplink access configuration. The example method further includes, in the same wireless device, receiving, in a first subframe, a first Orthogonal Frequency-Division Multiplexing (OFDM) transmission formatted according to a first numerology and receiving, in a second subframe, a second OFDM transmission formatted according to a second numerology, the second numerology differing from the first numerology. Variants of this method, corresponding apparatuses, and corresponding network-side methods and apparatuses are also disclosed.
    Type: Application
    Filed: January 2, 2024
    Publication date: December 19, 2024
    Inventors: Stefan Parkvall, Janne Peisa, Gunnar Mildh, Robert Baldemair, Stefan Wager, Jonas Kronander, Karl Werner, Richard Abrahamsson, Ismet Aktas, Peter Alriksson, Junaid Ansari, Shehzad Ali Ashraf, Henrik Asplund, Fredrik Athley, Håkan Axelsson, Joakim Axmon, Johan Axnäs, Kumar Balachandran, Gunnar Bark, Jan-Erik Berg, Andreas Bergström, Håkan Björkegren, Nadia Brahmi, Cagatay Capar, Anders Carlsson, Andreas Cedergren, Mikael Coldrey, Icaro L. J. da Silva, Erik Dahlman, Ali El Essaili, Ulrika Engström, Mårten Ericson, Erik Eriksson, Mikael Fallgren, Rui Fan, Gabor Fodor, Pål Frenger, Jonas Fridén, Jonas Fröberg Olsson, Anders Furuskär, Johan Furuskog, Virgile Garcia, Ather Gattami, Fredrik Gunnarsson, Ulf Gustavsson, Bo Hagerman, Fredrik Harrysson, Ning He, Martin Hessler, Kimmo Hiltunen, Songnam Hong, Dennis Hui, Jörg Huschke, Tim Irnich, Sven Jacobsson, Niklas Jaldén, Simon Järmyr, Zhiyuan Jiang, Martin Johansson, Niklas Johansson, Du Ho Kang, Eleftherios Karipidis, Patrik Karlsson, Ali S. Khayrallah, Caner Kilinc, Göran N. Klang, Sara Landström, Christina Larsson, Gen Li, Lars Lindbom, Robert Lindgren, Bengt Lindoff, Fredrik Lindqvist, Jinhua Liu, Thorsten Lohmar, Qianxi Lu, Lars Manholm, Ivana Maric, Jonas Medbo, Qingyu Miao, Reza Moosavi, Walter Müller, Elena Myhre, Karl Norrman, Bengt-Erik Olsson, Torgny Palenius, Sven Petersson, Jose Luis Pradas, Mikael Prytz, Olav Queseth, Pradeepa Ramachandra, Edgar Ramos, Andres Reial, Thomas Rimhagen, Emil Ringh, Patrik Rugeland, Johan Rune, Joachim Sachs, Henrik Sahlin, Vidit Saxena, Nima Seifi, Yngve Selén, Eliane Semaan, Sachin Sharma, Cong Shi, Johan Sköld, Magnus Stattin, Anders Stjernman, Dennis Sundman, Lars Sundström, Miurel Isabel Tercero Vargas, Claes Tidestav, Sibel Tombaz, Johan Torsner, Hugo Tullberg, Jari Vikberg, Peter von Wrycza, Thomas Walldeen, Pontus Wallentin, Hai Wang, Ke Wang Helmersson, Jianfeng Wang, Yi-Pin Eric Wang, Niclas Wiberg, Emma Wittenmark, Osman Nuri Can Yilmaz, Ali Zaidi, Zhan Zhang, Zhang Zhang, Yanli Zheng
  • Merged power delivery
    Patent number: 12170478
    Abstract: A power delivery sub-system included in a computer system employs a primary voltage regulator circuit that generates a primary supply voltage on a primary power supply node. The power delivery sub-system also includes multiple bypass voltage regulator circuits that source corresponding bypass currents to a local power supply nodes in an integrated circuit. The integrated circuit includes multiple circuit blocks coupled to corresponding ones of the local power supply nodes, and multiple local voltage regulator circuits coupled to the primary power supply node. When a voltage level of a given local power supply node drops below a threshold value, a corresponding local voltage regulator circuit sources a supply current to the given local power supply node.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: December 17, 2024
    Assignee: Apple Inc.
    Inventors: Alexander B. Uan-Zo-li, Shuai Jiang, Jamie L Langlinais, Per H. Hammarlund, Hans L Yeager, Victor Zyuban, Sung J. Kim, Wei Xu, Rohan U. Mandrekar, Sambasivan Narayan, Mohamed H. Abu-Rahma, Jaroslav Raszka, Robert O. Bruckner
  • Photovoltaic Devices and Methods for Producing Devices Using Perovskite Materials
    Publication number: 20240415008
    Abstract: Methods of making photovoltaic devices and photovoltaic devices including perovskite materials and having contact layers are described herein.
    Type: Application
    Filed: December 28, 2023
    Publication date: December 12, 2024
    Inventors: Joseph Jonathan BERRY, Robert TIRAWAT, Amy E. LOUKS, Kai ZHU, Axel Finn PALMSTROM, Qi JIANG, Kelly Robert SCHUTT, Mengjin YANG, Zhibo ZHAO, Severin Niklas HABISREUTINGER
  • METHOD OF DIRECTED DIFFERENTIATION PRODUCING CORNEAL ENDOTHELIAL CELLS, COMPOSITIONS THEREOF, AND USES THEREOF
    Publication number: 20240409892
    Abstract: This disclosure generally relates to cell-based therapies for treatment of visual disorders, including disorders of the cornea. Methods are exemplified for directed differentiation of corneal cells from stem cells. Compositions of corneal endothelial cells and uses thereof are also provided. Exemplary compositions exhibit improved cell density and/or more “youthful” gene expression relative to cells obtained from donated tissue.
    Type: Application
    Filed: June 13, 2024
    Publication date: December 12, 2024
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Kathryn L. McCabe, Shi-Jiang Lu, Robert P. Lanza
  • Compositions and methods for treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and associated methods for preparing said compositions
    Patent number: 12150958
    Abstract: The present disclosure provides, among other things, methods for the treatment of neurodegenerative diseases (ND) and other mitochondrial disorders, and compositions related thereto. Described herein are in vitro (cell culture) and in vivo (animal model) experimental examples demonstrating mitochondrial organelle transplantation (MOT) for the treatment of NDs such as amyotrophic lateral sclerosis (ALS). Furthermore, as discussed herein, MOT has been performed in five human ALS patients with positive results—measurable improvement of their conditions has been observed, with no adverse events.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: November 26, 2024
    Assignee: The Sallie Astor Burdine Breast Foundation
    Inventors: Robert L. Elliott, Xianpeng Jiang, Brent M. Segal
  • Personalizing automated conversational system based on predicted level of knowledge
    Patent number: 12141534
    Abstract: Techniques for personalizing an AI automated conversational system are provided. In one aspect, a method for personalizing an automated conversational system includes: making predictions of a familiarity of a user with concepts needed to understand a standard output utterance based on the familiarity of an aggregate of users and a background knowledge model of the concepts and related concepts, wherein the standard output utterance assumes that the concepts are known; and giving, by the automated conversational system, an output utterance that is tailored to the user given the predictions. For instance, the automated conversational system can give the standard output utterance to the user when it is predicted that the user is familiar with the concepts, or a nonstandard output utterance when it is it is predicted that the user is unfamiliar with at least one of the concepts.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: November 12, 2024
    Assignee: International Business Machines Corporation
    Inventors: Robert John Moore, Eric Young Liu, Shun Jiang, Chung-hao Tan, Lei Huang, Guangjie Ren, Sungeun An
  • GLASS CONTAINERS FOR STORING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240366474
    Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter di of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
    Type: Application
    Filed: July 17, 2024
    Publication date: November 7, 2024
    Inventors: Connor Thomas O'Malley, Sinue Gomez-Mower, Weirong Jiang, Joseph Michael Matusick, Christie Leigh McCarthy, Steven Edward DeMartino, John Stephen Peanasky, Shivani Rao Polasani, James Ernest Webb, Michael Clement Ruotolo, Jr., Bryan James Musk, Jared Seaman Aaldenberg, Eric Lewis Allington, Douglas Miles Noni, Jr., Amber Leigh Tremper, Kristen Dae Waight, Kevin Patrick McNelis, Patrick Joseph Cimo, Christy Lynn Chapman, Robert Anthony Schaut, Adam Robert Sarafian
  • Adaptation of secure sounding signal to bandwidth variation
    Patent number: 12132676
    Abstract: This disclosure describes systems, methods, and devices related to adaptation of secure sounding signal. A device may determine a negotiated bandwidth to be used when communicating with a first station device. The device may determine a first bit stream used to generate a cyclic shift diversity (CSD) value based on the negotiated bandwidth, wherein a first number of bits is used for the first bit stream when a first negotiated bandwidth is used, and wherein a second number of bits is used for the first bit stream when a second negotiated bandwidth is used. The device may determine a second bit stream used to generate a random phase. The device may determine a secure a long training field (LTF) based on a combination of the first bit stream and the second bit stream. The device may cause to send a frame to the first station device, wherein the frame comprises the secure LTF.
    Type: Grant
    Filed: March 27, 2023
    Date of Patent: October 29, 2024
    Assignee: Intel Corporation
    Inventors: Feng Jiang, Qinghua Li, Xiaogang Chen, Dibakar Das, Assaf Gurevitz, Jonathan Segev, Robert Stacey, Shlomi Vituri, Tzahi Weisman
  • ORGANOTIN PATTERNING MATERIALS WITH LIGANDS HAVING SILICON/GERMANIUM; PRECURSOR COMPOSITIONS; AND SYNTHESIS METHODS
    Publication number: 20240337941
    Abstract: As described herein, photosensitive composition comprises RSnL3, where R is a hydrocarbyl ligand with 1-20 carbon atoms and one or more silicon and/or germanium heteroatoms and L is an acetylide ligand (—C?CA, where A is a silyl group with 0 to 6 carbon atoms or an organo group with 1 to 10 carbon atoms). Methods are described wherein photosensitive compositions are synthesized by reacting RX, where X is a halide, and MSnL3, where M is an alkali metal, alkali earth metal or a pseudo-alkali earth metal, L is an acetylide or a dialkylamide. The radiation sensitive compositions are effective for radiation based patterning, such as with EUV light.
    Type: Application
    Filed: May 3, 2024
    Publication date: October 10, 2024
    Inventors: Robert E. Jilek, Kai Jiang, Amrit K. Narasimhan
  • Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
    Patent number: 12109239
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: October 8, 2024
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • MULTILAYER DISSOLVABLE SOLID ARTICLE AND METHOD OF MAKING SAME
    Publication number: 20240318105
    Abstract: A multilayer dissolvable solid article and method of making the same is described. The article has two or more flexible, dissolvable, porous sheets. Each of such two or more sheets has a Percent Open Cell Content of from about 80% to 100% and an Overall Average Pore Size of from about 100 ?m to about 2000 ?m. At least two adjacent sheets in such dissolvable solid article have an Adhesion Score (AdS) of no less than 1, while the contacting surfaces of said at least two adjacent sheets are essentially free of adhesives. Preferably, the multilayer dissolvable solid article is essentially free of adhesives.
    Type: Application
    Filed: June 7, 2024
    Publication date: September 26, 2024
    Inventors: Hongsing TAN, Robert Wayne GLENN, JR., Carl David MAC NAMARA, Ming TANG, Toshiyuki OKADA, Hongling CHEN, Xu HUANG, Gabrielle Alejandro NOGUEIRA MEZA, Min Jiang
  • Multilayer dissolvable solid article and method of making same
    Patent number: 12084631
    Abstract: This invention provides a multilayer dissolvable solid article, which comprises two or more flexible, dissolvable, porous sheets. Each of such two or more sheets is characterized by a Percent Open Cell Content of from about 80% to 100% and an Overall Average Pore Size of from about 100 ?m to about 2000 ?m and comprises a water-soluble polymer. At least two adjacent sheets in such dissolvable solid article are characterized by an Adhesion Score (AdS) of no less than 1, while the contacting surfaces of said at least two adjacent sheets are essentially free of adhesives. Preferably, the multilayer dissolvable solid article is essentially free of adhesives.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: September 10, 2024
    Assignee: The Procter & Gamble Company
    Inventors: Hongsing Tan, Robert Wayne Glenn, Jr., Carl David MacNamara, Ming Tang, Toshiyuki Okada, Hongling Chen, Xu Huang, Gabrielle Alejandro Nogueira Meza, Min Jiang
  • Methods for production of platelets from pluripotent stem cells and compositions thereof
    Patent number: 12076347
    Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: September 3, 2024
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Qiang Feng, Shi-Jiang Lu, Robert P. Lanza
  • Glass containers for storing pharmaceutical compositions
    Patent number: 12076297
    Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: September 3, 2024
    Assignee: Corning Incorporated
    Inventors: Joseph Michael Matusick, Sinue Gomez-Mower, Weirong Jiang, Steven Edward DeMartino, Christie Leigh McCarthy, Connor Thomas O'Malley, John Stephen Peanasky, Shivani Rao Polasani, James Ernest Webb, Michael Clement Ruotolo, Jr., Bryan James Musk, Jared Seaman Aaldenberg, Eric Lewis Allington, Douglas Miles Noni, Jr., Amber Leigh Tremper, Kristen Dae Waight, Kevin Patrick McNelis, Patrick Joseph Cimo, Christy Lynn Chapman, Robert Anthony Schaut, Adam Robert Sarafian
  • Glass containers for storing pharmaceutical compositions
    Patent number: 12076296
    Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
    Type: Grant
    Filed: September 30, 2022
    Date of Patent: September 3, 2024
    Assignee: Corning Incorporated
    Inventors: Steven Edward DeMartino, Sinue Gomez-Mower, Weirong Jiang, Joseph Michael Matusick, Christie Leigh McCarthy, Connor Thomas O'Malley, John Stephen Peanasky, Shivani Rao Polasani, James Ernest Webb, Michael Clement Ruotolo, Jr., Bryan James Musk, Jared Seaman Aaldenberg, Eric Lewis Allington, Douglas Miles Noni, Jr., Amber Leigh Tremper, Kristen Dae Waight, Kevin Patrick McNelis, Patrick Joseph Cimo, Christy Lynn Chapman, Robert Anthony Schaut, Adam Robert Sarafian
  • GLASS CONTAINERS FOR STORING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240285471
    Abstract: A glass cartridge comprises a cylindrical body portion comprising an outer diameter Dc and an average sidewall thickness Tc, the cylindrical body portion having a first end and a second end opposite the first end; an opening at the first end of the cylindrical body portion; a shoulder extending radially inward from the second end of the cylindrical body portion; and a neck extending from the shoulder and comprising an outer neck diameter NOD that is less than the outer diameter Dc of the cylindrical body portion. The average wall thickness Tc is less than or equal to 0.85*s1, wherein s1 is a wall thickness of a standard glass cartridge defined by ISO 13926-1:2004 having an outer diameter d1 that is closer to the outer diameter Dc than the outer diameter d1 of any other standard glass cartridge defined by ISO 13926-1:2004.
    Type: Application
    Filed: April 5, 2024
    Publication date: August 29, 2024
    Applicant: CORNING INCORPORATED
    Inventors: Connor Thomas O'Malley, Sinue Gomez-Mower, Weirong Jiang, Joseph Michael Matusick, Christie Leigh McCarthy, Christy Lynn Chapman, John Stephen Peanasky, Shivani Rao Polasani, James Ernest Webb, Michael Clement Ruotolo, Jr., Bryan James Musk, Jared Seaman Aaldenberg, Eric Lewis Allington, Douglas Miles Noni, Jr., Amber Leigh Tremper, Kristen Dae Waight, Kevin Patrick McNelis, Patrick Joseph Cimo, Steven Edward DeMartino, Robert Anthony Schaut, Adam Robert Sarafian, Alicia Marie Gallagher
  • Corneal endothelial cells with increased cell density and compositions thereof
    Patent number: 12049642
    Abstract: This disclosure generally relates to cell-based therapies for treatment of visual disorders, including disorders of the cornea. Methods are exemplified for directed differentiation of corneal cells from stem cells. Compositions of corneal endothelial cells and uses thereof are also provided. Exemplary compositions exhibit improved cell density and/or more “youthful” gene expression relative to cells obtained from donated tissue.
    Type: Grant
    Filed: August 1, 2017
    Date of Patent: July 30, 2024
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Kathryn L. McCabe, Shi-Jiang Lu, Robert P. Lanza
  • Secure sounding signal without unintentional beamforming effect
    Patent number: 12052080
    Abstract: This disclosure describes systems, methods, and devices related to secure sounding signal. A device may generate two or more sounding signals to be sent using two or more antennas to a receiving device across a plurality of symbol intervals. The device may apply a first masking signal to a first sounding signal of the two or more sounding signals over a first symbol interval of the plurality of the symbol intervals. The device may apply a second masking signal to a second sounding signal over a second symbol interval of the plurality of the symbol intervals. The device may cause to send the two or more sounding signals to receiving device using the two or more antennas.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: July 30, 2024
    Assignee: Intel Corporation
    Inventors: Qinghua Li, Xiaogang Chen, Assaf Gurevitz, Feng Jiang, Xintian Lin, Jonathan Segev, Gadi Shor, Robert Stacey
  • SELECTED COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
    Publication number: 20240245677
    Abstract: Selected BRD9 protein degradation compounds and morphic forms thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.
    Type: Application
    Filed: March 8, 2024
    Publication date: July 25, 2024
    Applicant: C4 THERAPEUTICS, INC.
    Inventors: Katrina L. Jackson, Christopher G. Nasveschuk, Rhamy Zeid, Ning Yin, Gesine Kerstin Veits, Moses Moustakim, Jeremy L. Yap, Minsheng He, Robert T. Yu, Matthew J. Schnaderbeck, Kathleen Neville, Siyi Jiang, Meiqi Li, Qianwei Liu, Manjie Zheng, Jia Li, Liwei Zhang
  • Fused heterocyclic compounds as ion channel modulators
    Patent number: 9371329
    Abstract: The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein W1, W2, W3, R1, Q, X1, X2 and X3 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: June 21, 2016
    Assignee: Gilead Sciences, Inc.
    Inventors: Britton Corkey, Elfatih Elzein, Robert Jiang, Rao Kalla, Tetsuya Kobayashi, Dmitry Koltun, Xiaofen Li, Gregory Notte, Eric Parkhill, Thao Perry, Jeff Zablocki